Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico

Mario Escobar Gómez, Ana Maria Rodríguez-Leboeuf, Selene Camargo-Correa, Ida Caterina García-Appendini, Arti Dhar, Isabela Rivas, Juan Guillermo Ariza, Pedro A Madero-Morales · 2026

Read Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico by Mario Escobar Gómez, Ana Maria Rodríguez-Leboeuf, Selene Camargo-Correa, Ida Caterina García-Appendini, Arti Dhar, Isabela Rivas, Juan Guillermo Ariza, Pedro A Madero-Morales (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13575021.txt.

Description

Mario Escobar Gómez leads a 2026 study of how pill features shape prostate cancer treatment choices in Mexico. The drugs in focus block the androgen receptor pathway, a key driver of this cancer. Features such as pill size, shape, count, and dosing schedule may affect whether patients keep taking them.

The work mixed a literature review, expert surveys and interviews, focus groups, and statistical modelling. Clinicians put dosing frequency at the top, with pill count next, among influences on adherence when drug effects were equal. Regimens of two pills or fewer per day, taken once daily, were favoured. Model results matched the expert views. The authors suggest patient-friendly formulations deserve a place in shared treatment decisions.

Catalog record

CREATORMario Escobar Gómez, Ana Maria Rodríguez-Leboeuf, Selene Camargo-Correa, Ida Caterina García-Appendini, Arti Dhar, Isabela Rivas, Juan Guillermo Ariza, Pedro A Madero-Morales
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40771
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13575021

Browse the full library · About the Tower of Babel